Nothing Special   »   [go: up one dir, main page]

ES2093829T3 - Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias. - Google Patents

Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias.

Info

Publication number
ES2093829T3
ES2093829T3 ES92909536T ES92909536T ES2093829T3 ES 2093829 T3 ES2093829 T3 ES 2093829T3 ES 92909536 T ES92909536 T ES 92909536T ES 92909536 T ES92909536 T ES 92909536T ES 2093829 T3 ES2093829 T3 ES 2093829T3
Authority
ES
Spain
Prior art keywords
asthma
treatment
pharmaceutical composition
respiratory tract
tract diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92909536T
Other languages
English (en)
Inventor
Jesus Covarrubias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott France SA
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Procter and Gamble Pharmaceuticals France SA
Procter and Gamble Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Pharmaceuticals France SA, Procter and Gamble Pharmaceuticals Inc filed Critical Procter and Gamble Pharmaceuticals France SA
Application granted granted Critical
Publication of ES2093829T3 publication Critical patent/ES2093829T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UNA FORMA DE ADMINISTRACION DE LA TAURINA QUE PROCURA UNA NUEVA INDICACION TERAPEUTICA. LA COMPOSICION FARMACEUTICA CONTIENE TAURINA O HIPOTAURINA EN COMBINACION CON MEDIOS PARA SU ADMINISTRACION POR INHALACION, EN PARTICULAR EN FORMA DE AEROSOL, ESTANDO COMPRENDIDA LA CONCENTRACION DE LA TAURINA ENTRE 5G/L Y 50G/L DE SOLVENTE. APLICACION PARA EL TRATAMIENTO DEL ASMA Y DE LAS AFECCIONES DE LAS VIAS RESPIRATORIAS.
ES92909536T 1991-03-27 1992-03-27 Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias. Expired - Lifetime ES2093829T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9103693A FR2674434B1 (fr) 1991-03-27 1991-03-27 Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.

Publications (1)

Publication Number Publication Date
ES2093829T3 true ES2093829T3 (es) 1997-01-01

Family

ID=9411170

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92909536T Expired - Lifetime ES2093829T3 (es) 1991-03-27 1992-03-27 Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias.

Country Status (14)

Country Link
EP (1) EP0533896B1 (es)
JP (1) JPH06501954A (es)
KR (1) KR100196060B1 (es)
AT (1) ATE142874T1 (es)
AU (1) AU656775B2 (es)
BR (1) BR9204815A (es)
CA (1) CA2083825A1 (es)
DE (1) DE69213874T2 (es)
DK (1) DK0533896T3 (es)
ES (1) ES2093829T3 (es)
FR (1) FR2674434B1 (es)
GR (1) GR3022083T3 (es)
NO (1) NO301521B1 (es)
WO (1) WO1992017170A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696080B1 (fr) * 1992-09-30 1994-12-23 Jesus Covarrubias Filtre à cigarette pour l'administration de taurine par inhalation.
US6709670B1 (en) 1999-07-02 2004-03-23 Nippon Chemical Works Co., Ltd. Aminoethanesulfonic acid-containing preparations
KR100368011B1 (ko) * 2000-03-23 2003-01-14 조금호 타우린을 함유하는 경장유동액
FR2833839A1 (fr) * 2001-12-21 2003-06-27 Rytek Methodes et compositions pour le traitement de pathologies respiratoires
FR2833840B1 (fr) * 2001-12-21 2010-06-18 Rytek Methodes et compositions pour le traitement de pathologies respiratoires
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
DE102007040615A1 (de) * 2007-08-27 2009-03-05 Bitop Ag Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
GB201305813D0 (en) * 2013-03-28 2013-05-15 Vectura Ltd Compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226897B (it) * 1987-09-18 1991-02-21 Richerche Di Schiena Snc Del D Derivato di taurina, sua preparazione e composizioni farmaceutiche relative
JPH0368549A (ja) * 1989-08-07 1991-03-25 Yamanouchi Pharmaceut Co Ltd タウリン誘導体及びこれを有効成分とするロイコトリエン拮抗剤

Also Published As

Publication number Publication date
KR930700088A (ko) 1993-03-13
KR100196060B1 (ko) 1999-06-15
FR2674434B1 (fr) 1993-06-18
ATE142874T1 (de) 1996-10-15
BR9204815A (pt) 1993-07-27
FR2674434A1 (fr) 1992-10-02
EP0533896B1 (fr) 1996-09-18
AU656775B2 (en) 1995-02-16
EP0533896A1 (fr) 1993-03-31
DE69213874T2 (de) 1997-04-03
CA2083825A1 (fr) 1992-09-28
NO301521B1 (no) 1997-11-10
NO924578L (no) 1992-11-26
DE69213874D1 (de) 1996-10-24
DK0533896T3 (es) 1997-02-17
JPH06501954A (ja) 1994-03-03
NO924578D0 (no) 1992-11-26
GR3022083T3 (en) 1997-03-31
AU1665992A (en) 1992-11-02
WO1992017170A1 (fr) 1992-10-15

Similar Documents

Publication Publication Date Title
DE69232462D1 (de) Formoterol und budesonide enthaltende zusammensetzung
FR2651677B1 (fr) Composition pharmaceutique a base de salmeterol et du propionate de fluticasone.
ES2173947T3 (es) Uso de furoato de mometasona para tratar enfermedades pulmonares y de las vias aereas.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ES2092539T3 (es) Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
ES2093829T3 (es) Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias.
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
SE8500996D0 (sv) Method of treatment
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
BR0015329A (pt) Uso de óxido nìtrico para o tratamento de constrição das vias aéreas
ES2124926T3 (es) Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas.
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
KR870700349A (ko) 만성 폐색성 폐질환의 치료방법 및 조성물
Prober Ribavirin: A new weapon against respiratory viruses?.
KR890003399A (ko) 약리적 활성 화합물 및 용도
RU93003454A (ru) Лекарственный препарат

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 533896

Country of ref document: ES